More on ONWRY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.57 |
|
|||
| Open | $3.57 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $3.57 | ||||
| Day Low | $3.57 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1 | ||||
- ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders
- ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions
- ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
- ONWARD Medical receives FDA clearance for home use of spinal cord device
- ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
- ONWARD Medical gains European approval for spinal cord device
- ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe
- ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025
- ONWARD Medical appoints Lucas Buchanan to board of directors
- ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors
Entities mentioned with ONWRY
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Warburg Pincus | View Related Stories »
- IPO | View Related Stories »
- Dividend | View Related Stories »
- Show More...
